DFDA

Lisinopril (Blood Pressure Lowering)

Treatment for Ischemic Stroke

Typical Dosage: 10-40 mg daily

Effectiveness
65%
Safety Score
70%
Clinical Trials
200
Participants
200K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
70
DangerousModerateSafe
Treatment Details
Dosage Range
10-40 mg daily
Time to Effect
days to weeks
Treatment Duration
lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
30(Treat 30 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
500(Treat 500 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$50
Monitoring:$100
Side Effect Mgmt:$100
Total Annual:$250
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$5,000/QALY
QALYs Gained
0.5
Outcome-Based Costs
Cost per Responder
$1,000
Comparison vs Placebo
Cost Difference
+$250/year
More expensive
QALY Difference
+0.50 QALYs
Better outcomes
Dominance
No dominance
Lisinopril (Blood Pressure Lowering) Outcomes

for Ischemic Stroke

Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+25%
Common Side Effects
Cough
+7%
Dizziness/Hypotension
+3%
Angioedema
+0.5%

Sources:

nih.gov
oup.com
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov